Nomura Asset Management’s Integra LifeSciences IART Stock Holding History

Nomura Asset Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$22.3K	Buy	+1,240	New	+$17.3K	﹤0.01%	1272
2026 Q1	–	Sell	-1,200	Closed	-$14.9K	–	1563
2025 Q4	$14.9K	Hold	1,200	–	–	﹤0.01%	1469
2025 Q3	$17.2K	Hold	1,200	–	–	﹤0.01%	1463
2025 Q2	$14.7K	Hold	1,200	–	–	﹤0.01%	1490
2025 Q1	$26.4K	Buy	+1,200	New	+$28.2K	﹤0.01%	1326
2024 Q3	–	Sell	-250	Closed	-$7.29K	–	1505
2024 Q2	$7.29K	Hold	250	–	–	﹤0.01%	1495
2024 Q1	$8.86K	Hold	250	–	–	﹤0.01%	1498
2023 Q4	$10.9K	Hold	250	–	–	﹤0.01%	1484
2023 Q3	$9.55K	Hold	250	–	–	﹤0.01%	1500
2023 Q2	$10.3K	Hold	250	–	–	﹤0.01%	1503
2023 Q1	$14.4K	Hold	250	–	–	﹤0.01%	1464
2022 Q4	$14K	Hold	250	–	–	﹤0.01%	1406
2022 Q3	$10.6K	Hold	250	–	–	﹤0.01%	1469
2022 Q2	$13.5K	Hold	250	–	–	﹤0.01%	1457
2022 Q1	$16.1K	Buy	+250	New	+$16.5K	﹤0.01%	1477

Other funds holding IART

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Nomura Asset Management's IART Position: Q2 2026 in Review

Nomura Asset Management opened a new position in Integra LifeSciences (IART) in Q2 2026: 1,240 shares worth $22.3K. The stake represents ﹤0.01% of the portfolio and ranks #1272 among its holdings. This is a return to the name: Nomura Asset Management previously reported a position in IART as recently as Q4 2025.

Nomura Asset Management first reported a position in IART in Q1 2022 and has held it in 15 quarters since. The position peaked at $26.4K in Q1 2025. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

Nomura Asset Management held 1,240 shares of Integra LifeSciences worth $22.3K as of Q2 2026.
Integra LifeSciences was a new Nomura Asset Management position in Q2 2026.
Integra LifeSciences made up ﹤0.01% of Nomura Asset Management's portfolio in Q2 2026, its #1272 holding.
Nomura Asset Management first reported a position in Integra LifeSciences in Q1 2022 and has held it in 15 quarters since.
Nomura Asset Management's Integra LifeSciences position peaked at $26.4K in Q1 2025.
212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Nomura Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.